« Back to Record
Citation APA

Loi, S., Salgado, R., Piette, F., Sirtaine, N., Van Eenoo, F., Kammler, R., Rouas, G., Francis, P., Crown, J., Nordenskjöld, B., Gutierrez, J., Andersson, M., Vila, M. M., Jakesz, R., Viale, G., Quinaux, E., Di Leo, A., Michiels, S., Sotiriou, C., & Piccart-Gebhart, M. (2011). Evaluation of the prognostic and predictive value of tumor-infiltrating lymphocytes (TILs) in a phase III randomized adjuvant breast cancer (BC) trial (BIG 2-98) of node-positive (N+) BC comparing the addition of docetaxel to doxorubicin (A-T) with doxorubicin (A)-only chemotherapy (CT). J Clin Oncol: ASCO Annual Meeting Proceedings. Vol. 29, 15 Suppl, Part I (p. 59) Abstract session presented at ASCO Annual meeting 2011(June, 2011: Chicago, Il, USA).


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/159047

Loi, S., Salgado, R., Piette, F., Sirtaine, N., Van Eenoo, F., Kammler, R., Rouas, G., Francis, P., Crown, J., Nordenskjöld, B., Gutierrez, J., Andersson, M., Vila, M. M., Jakesz, R., Viale, G., Quinaux, E., Di Leo, A., Michiels, S., Sotiriou, C., & Piccart-Gebhart, M. (2011). Evaluation of the prognostic and predictive value of tumor-infiltrating lymphocytes (TILs) in a phase III randomized adjuvant breast cancer (BC) trial (BIG 2-98) of node-positive (N+) BC comparing the addition of docetaxel to doxorubicin (A-T) with doxorubicin (A)-only chemotherapy (CT). J Clin Oncol: ASCO Annual Meeting Proceedings. Vol. 29, 15 Suppl, Part I (p. 59) Abstract session presented at ASCO Annual meeting 2011(June, 2011: Chicago, Il, USA).